Cannabis can relieve certain types of stomach pain in some people, but the clinical evidence is far weaker and more condition-specific than popular reputation suggests. Across the gastrointestinal conditions where it has been formally studied, results range from modestly promising to flatly negative, and for one well-documented syndrome, cannabis itself is the cause of severe abdominal pain. The gut is loaded with cannabinoid receptors, which gives the idea biological plausibility, but plausibility and proof are different things.
Why the Gut Responds to Cannabis at All
Your gastrointestinal tract has its own network of cannabinoid receptors, the same molecular targets that THC and CBD bind to elsewhere in the body. CB1 receptors sit throughout the gut, mainly on neurons in the intestinal wall and in the brain regions that process visceral signals. CB2 receptors concentrate in immune and inflammatory cells lining the intestines, with a smaller presence on gut neurons.1PubMed. Endocannabinoids and the gastrointestinal tract One study examining colon tissue found CB1 receptors in normal intestinal lining, smooth muscle, and nerve networks, while CB2 showed up on immune cells in the gut wall and was especially prominent in inflamed tissue from people with inflammatory bowel disease.2PubMed. Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing
This receptor distribution matters because it means cannabinoids can, in theory, influence gut motility, pain signaling, inflammation, and immune responses. The body even produces its own cannabinoid-like molecules (endocannabinoids) as part of normal gut regulation. Some researchers have proposed that a shortfall in endocannabinoid signaling could contribute to painful functional gut disorders like irritable bowel syndrome.3PubMed Central. Irritable Bowel Syndrome: Manipulating the Endocannabinoid System as First-Line Treatment That hypothesis is intriguing but still largely theoretical. Having the biological hardware in place does not automatically mean that smoking or eating cannabis will fix what hurts.
Inflammatory Bowel Disease
Crohn’s disease and ulcerative colitis are the conditions where you would most expect cannabinoids to help, given all those CB2 receptors sitting on gut immune cells. People with IBD frequently report using cannabis for symptom relief, and surveys consistently show they feel it helps. When researchers have tested this in controlled trials, though, the picture is discouraging.
A meta-analysis that screened hundreds of studies on cannabis for IBD found that only three randomized trials met basic quality standards: two for Crohn’s disease and one for ulcerative colitis. In the ulcerative colitis trial, there was no difference in achieving remission or clinical response between cannabis and placebo. In the Crohn’s trials, the results were similarly unimpressive, with no statistically significant improvement in remission rates. Adverse events, meanwhile, occurred in all patients receiving cannabis in the ulcerative colitis study.4PubMed Central. Evidence supporting the benefits of marijuana for Crohn’s disease and ulcerative colitis is extremely limited: a meta-analysis of the literature
A large observational study from Canada added another wrinkle. Among people with IBD, those who recently used cannabis actually reported more abdominal pain, poorer appetite, and more flatulence than non-users, along with lower quality-of-life scores on a validated IBD questionnaire.5Crohn’s & Colitis 360. Cannabis Use in Patients With Inflammatory Bowel Disease Following Legalization of Cannabis in Canada That does not necessarily mean cannabis made them worse; people in more pain may be more likely to try cannabis. But it does undercut the narrative that cannabis reliably eases IBD symptoms in practice.
Irritable Bowel Syndrome
IBS is the most common reason people experience chronic stomach pain, and it is where the endocannabinoid deficiency hypothesis gets the most attention. The logic is straightforward: if underactive endocannabinoid signaling contributes to the heightened pain sensitivity seen in IBS, then supplementing with plant cannabinoids should help. So far, that logic has not translated into convincing trial data.
A crossover study testing CBD chewing gum in IBS patients found no statistically significant difference in pain scores between CBD and placebo at the group level. Individual responses were all over the map, with some participants appearing to improve and others not, but nothing that would pass as a reliable treatment effect.6PubMed Central. Effects of Cannabidiol Chewing Gum on Perceived Pain and Well-Being of Irritable Bowel Syndrome Patients: A Placebo-Controlled Crossover Exploratory Intervention Study with Symptom-Driven Dosing
One challenge researchers face is that IBS responds strongly to placebo. A large systematic review found that about a third of IBS patients in drug trials improved on placebo alone when abdominal pain was the endpoint, and about a quarter showed global improvement on sugar pills.7PubMed. The placebo response rate in pharmacological trials in patients with irritable bowel syndrome: a systematic review and meta-analysis That high background improvement rate means any real drug effect has to be quite strong to stand out, and cannabis has not cleared that bar in published trials. When someone tells you cannabis helped their IBS, it may genuinely have, but it is also possible they would have improved with any intervention they believed in.
Gastroparesis and Nausea
Gastroparesis, where the stomach empties food too slowly, is an interesting case because cannabis has contradictory effects. THC has long been used to suppress nausea, particularly nausea from chemotherapy, and that anti-nausea action extends to some gastroparesis symptoms. A review of cannabinoid effects on the GI tract found that CBD reduced overall gastroparesis symptom scores and improved patients’ ability to tolerate meals over four weeks of treatment. However, the same review noted that pain-dominant symptoms in functional dyspepsia with normal stomach emptying were not significantly improved by CBD.8PubMed Central. Cannabinoids and the Gastrointestinal Tract
Here is the catch: THC slows gastric emptying, which is the exact opposite of what people with gastroparesis need. Research has shown that dronabinol (a synthetic THC) delays gastric emptying of solid food, an effect seen predominantly in women. In men, it increased fasting stomach volume. Both sexes showed significant suppression of normal colon contractions after meals.9PubMed Central. Cannabinoids and Gastrointestinal Motility: Pharmacology, Clinical Effects and Potential Therapeutics in Humans So while cannabinoids might ease the nausea that comes with gastroparesis, chronic use could make the underlying stomach-emptying problem worse.10PubMed Central. Marijuana Use in Patients with Symptoms of Gastroparesis: Prevalence, Patient Characteristics, and Perceived Benefit That creates a trap where symptom relief and disease progression can happen simultaneously.
Cannabis as a Cause of Stomach Pain
Perhaps the most important thing to know if you are using cannabis for stomach pain is that cannabis itself can cause severe stomach pain. Cannabinoid hyperemesis syndrome (CHS) is a condition seen in chronic, heavy cannabis users, marked by cycles of intense nausea, vomiting, and abdominal pain that can be debilitating enough to send people to the emergency room.11PubMed Central. Cannabinoid Hyperemesis Syndrome: A Rare Cause of Severe Abdominal Pain and Hyperlactataemia People with CHS often find that hot showers or baths temporarily relieve their symptoms, which is one of the clinical clues doctors use to identify it.
The irony is thick: someone starts using cannabis for stomach discomfort, finds that it helps at first, gradually increases their use, and eventually develops CHS, which causes worse stomach pain than they started with. Because these people associate cannabis with relief rather than harm, they often increase their use further, deepening the cycle. CHS resolves when cannabis use stops, but that can be a difficult conversation when someone is convinced cannabis is the only thing helping them. Emergency departments in states with legal cannabis have seen a notable increase in CHS presentations, and it is likely still underdiagnosed because many patients do not disclose their cannabis use or connect it to their symptoms.
What Cannabis Does to Gut Motility
Even setting aside specific disease conditions, cannabis has measurable effects on how your digestive system moves things along. A large nationwide cohort study found that recent marijuana use was associated with about a 30% lower likelihood of constipation compared to non-users, even after adjusting for diet, medications, physical activity, and other substance use. There was no association between marijuana use and diarrhea.12PubMed. Relationship Between Recreational Marijuana Use and Bowel Function in a Nationwide Cohort Study That might sound like good news, but the mechanism is worth understanding. Cannabinoids broadly inhibit normal gut contractions and slow transit, as noted earlier. The reason this does not translate into more constipation in the real-world data may reflect dose, frequency, tolerance, or other factors that observational studies cannot fully untangle.
The motility-slowing effect is consistent across lab and human studies. Dronabinol suppressed both fasting and post-meal contraction patterns in the colon, and this suppression was described as profound.9PubMed Central. Cannabinoids and Gastrointestinal Motility: Pharmacology, Clinical Effects and Potential Therapeutics in Humans For someone whose stomach pain comes from spasm or overactive gut contractions, that calming effect could genuinely help. For someone whose pain relates to slow transit or bloating from poor motility, it could make things worse. The condition matters enormously.
THC and CBD Are Not the Same Story
Much of the confusion around cannabis and stomach pain stems from lumping THC and CBD together. They bind to different receptors with different effects and have different anti-inflammatory profiles. A systematic review of animal studies found that CBD, CBG, or CBD combined with THC consistently reduced levels of key inflammatory molecules. THC alone did not produce the same anti-inflammatory effect.13PubMed Central. The Effects of Cannabinoids on Pro- and Anti-Inflammatory Cytokines: A Systematic Review of In Vivo Studies That distinction matters if you are trying to address inflammation-driven pain, as in IBD. It also means that studies of whole-plant cannabis, which contains both THC and CBD along with dozens of other compounds, cannot be cleanly compared to studies of purified CBD or synthetic THC.
Most people using cannabis for stomach pain are using products with significant THC content, since THC is what provides the psychoactive effect and what most people mean when they say “weed.” CBD-only products are increasingly available but have different (and generally subtler) effects on the gut. The gastroparesis research illustrates this split: CBD showed promise for overall symptom relief, while THC-like compounds slowed stomach emptying in ways that could worsen the condition. If you are considering cannabis for stomach pain, which cannabinoid you use, and how much, is not a minor detail.
The Opioid Reduction Angle
One argument for cannabis in gut pain management comes from a different direction entirely: it might allow people to reduce their use of opioid painkillers. A systematic review of observational studies involving over 7,000 participants found that non-cancer chronic pain patients who used medical cannabis alongside opioids reduced their opioid dose by roughly two-thirds, and about a third to over half of patients used cannabis as a partial or complete opioid substitute.14PubMed Central. Medical cannabis for the reduction of opioid dosage in the treatment of non-cancer chronic pain: a systematic review A more recent study in JAMA Internal Medicine confirmed a dose-response relationship: compared to periods with no medical cannabis dispensed, a 30-day supply of medical cannabis was associated with a reduction of about 3.5 daily morphine milligram equivalents.15PubMed Central. Medical Cannabis and Opioid Receipt Among Adults With Chronic Pain
Opioids are themselves terrible for the gut. They slow motility, cause constipation, and can worsen the pain cycle over time through opioid-induced hyperalgesia. If cannabis allows someone with chronic visceral pain to take fewer opioids, that trade-off might be worthwhile even if the cannabis itself is not directly treating the underlying condition. This is a pragmatic rather than mechanistic argument, and it resonates with many pain specialists who have watched opioids cause enormous harm in their patients.
The Microbiome Connection
A newer area of research examines how cannabinoids interact with gut bacteria. A systematic review identified nine studies, a mix of clinical trials and observational work, examining the effects of cannabis and cannabinoids on microbial diversity in the gut and elsewhere. The findings suggest that cannabis use can alter microbial diversity, though the direction and magnitude depend on the clinical context. The review also found a positive association between the body’s own endocannabinoids and gut bacteria that produce short-chain fatty acids, which are molecules linked to reduced inflammation.16PubMed Central. Cannabis and cannabinoid-microbiome interactions in varied clinical contexts: A comprehensive systematic review This is very early-stage science, but it hints at another mechanism through which cannabinoids could influence gut health, one that does not involve pain receptors at all.
What a Gastroenterologist Would Actually Tell You
If you walked into a GI clinic and asked whether to use cannabis for your stomach pain, the honest answer from most specialists would be something like: we do not have enough good data to recommend it, but we understand why patients try it. The evidence base is thin for almost every GI condition. The few randomized trials that exist are small, and the observational studies are confounded by the fact that sicker people are more likely to use cannabis. Changes in legalization and public perception of cannabis have outpaced the research, leaving clinicians in a bind where patients are already using something that science has not adequately evaluated.17Clinical Gastroenterology and Hepatology. Pharmacology, Clinical Effects, and Therapeutic Potential of Cannabinoids for Gastrointestinal and Liver Diseases
The strongest honest counsel is condition-specific. For nausea-predominant symptoms, particularly in gastroparesis, there is some evidence of benefit, though with caveats about long-term motility effects. For inflammatory bowel disease and IBS, the controlled trial evidence is either absent or negative, despite widespread patient-reported benefit. For anyone using cannabis daily and experiencing worsening cyclical vomiting and abdominal pain, stopping cannabis entirely for a trial period is essential to rule out CHS. And for anyone currently managing pain with opioids, a supervised conversation about whether medical cannabis could reduce that opioid burden is a reasonable thing to bring up with a doctor who is open to the discussion.
What the science does not support is the blanket claim that “weed helps with stomach pain.” It might, depending on what is causing the pain, which cannabinoid you use, how much and how often you use it, and whether the relief you feel reflects a pharmacological effect or a very strong placebo response in a body system that is famously responsive to expectation. The biology is real. The clinical proof, for now, is not.